Chemoresistance pathways in DLBCL

Blood. 2023 Sep 14;142(11):943-944. doi: 10.1182/blood.2023021142.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Drug Resistance, Neoplasm* / genetics
  • Humans
  • Mutation
  • Receptor, Notch2
  • Ubiquitins*

Substances

  • Ubiquitins
  • NOTCH2 protein, human
  • Receptor, Notch2